[go: up one dir, main page]

NO965411D0 - N-terminally extended proteins expressed in yeast - Google Patents

N-terminally extended proteins expressed in yeast

Info

Publication number
NO965411D0
NO965411D0 NO965411A NO965411A NO965411D0 NO 965411 D0 NO965411 D0 NO 965411D0 NO 965411 A NO965411 A NO 965411A NO 965411 A NO965411 A NO 965411A NO 965411 D0 NO965411 D0 NO 965411D0
Authority
NO
Norway
Prior art keywords
yeast
proteins expressed
terminally extended
extended proteins
terminally
Prior art date
Application number
NO965411A
Other languages
Norwegian (no)
Other versions
NO965411L (en
Inventor
Knud Vad
Jakob Brandt
Thomas Boerglum Kjeldsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO965411D0 publication Critical patent/NO965411D0/en
Publication of NO965411L publication Critical patent/NO965411L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO965411A 1994-06-17 1996-12-16 N-terminally extended proteins expressed in yeast NO965411L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK71294 1994-06-17
PCT/DK1995/000250 WO1995035384A1 (en) 1994-06-17 1995-06-16 N-terminally extended proteins expressed in yeast

Publications (2)

Publication Number Publication Date
NO965411D0 true NO965411D0 (en) 1996-12-16
NO965411L NO965411L (en) 1997-02-14

Family

ID=8096676

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965411A NO965411L (en) 1994-06-17 1996-12-16 N-terminally extended proteins expressed in yeast

Country Status (16)

Country Link
EP (1) EP0765395A1 (en)
JP (1) JP3730255B2 (en)
CN (1) CN1131312C (en)
AU (1) AU2733595A (en)
BR (1) BR9508053A (en)
CA (1) CA2192943A1 (en)
CZ (1) CZ363796A3 (en)
FI (1) FI965030A7 (en)
HU (1) HUT75840A (en)
IL (1) IL114160A (en)
MX (1) MX9606536A (en)
NO (1) NO965411L (en)
PL (1) PL317761A1 (en)
SG (1) SG47883A1 (en)
WO (1) WO1995035384A1 (en)
ZA (1) ZA954983B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
US6017731A (en) 1996-12-13 2000-01-25 Chiron Corporation Method for expression of heterologous proteins in yeast
ATE317443T1 (en) * 1996-12-20 2006-02-15 Novo Nordisk As N-TERMINAL EXTENDED PROTEINS EXPRESSED IN YEAST
EP1049790A1 (en) * 1998-01-23 2000-11-08 Novo Nordisk A/S Process for making desired polypeptides in yeast
DE60044728D1 (en) 1999-12-29 2010-09-02 Novo Nordisk As METHOD FOR THE PRODUCTION OF INSULIN FORECASTS AND ANALOGS OF INSULIN PROCESSORS WITH IMPROVED FERMENTATION EXPORTS IN YEAST
US20030082671A1 (en) 2001-07-24 2003-05-01 Thomas Hoeg-Jensen Method for making acylated polypeptides
US7595172B2 (en) 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides
EP1421102A2 (en) * 2001-07-24 2004-05-26 Novo Nordisk A/S Method for making acylated polypeptides
WO2004085472A1 (en) * 2003-03-27 2004-10-07 Novo Nordisk A/S Method for making human insulin precursors and human insulin
CN1902226A (en) 2003-12-03 2007-01-24 诺和诺德公司 Single-chain insulin
ATE513921T1 (en) 2005-08-16 2011-07-15 Novo Nordisk As METHOD FOR PRODUCING MATURE INSULIN POLYPEPTIDES
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
BRPI0717098B8 (en) 2006-09-22 2021-05-25 Novo Nordisk As protease-resistant human insulin analogues, pharmaceutical composition and process for their preparation
EP2069502B1 (en) 2006-09-27 2014-02-26 Novo Nordisk A/S Method for making maturated insulin polypeptides
WO2008062010A2 (en) 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases
CN101743252A (en) 2007-07-16 2010-06-16 诺沃-诺迪斯克有限公司 protease stabilized, pegylated insulin analogues
EP2178909B1 (en) 2007-08-13 2015-10-21 Novo Nordisk A/S Rapid acting insulin analogues
CN101784562B (en) 2007-08-15 2016-07-13 诺沃-诺迪斯克有限公司 There is the insulin analog of acyl group and aklylene glycol moiety
EP2178910B1 (en) 2007-08-15 2014-10-08 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
PT2254906T (en) 2008-03-18 2017-01-03 Novo Nordisk As Protease stabilized, acylated insulin analogues
CN102065903B (en) 2008-04-01 2015-02-18 诺沃-诺迪斯克有限公司 Insulin albumin conjugates
RU2533217C3 (en) 2009-06-26 2020-12-21 Ново Нордиск А/С PREPARATION CONTAINING INSULIN, NICOTINAMIDE AND AMINO ACID
CN102639559B (en) 2009-11-25 2015-04-29 诺沃—诺迪斯克有限公司 Methods for preparing polypeptides
BR112012033107A2 (en) 2010-06-23 2016-10-11 Novo Nordisk As insulin derivatives containing additional disulfide bonds.
US8883722B2 (en) 2010-06-23 2014-11-11 Novo Nordisk A/S Human insulin containing additional disulfide bonds
US8815798B2 (en) 2010-06-23 2014-08-26 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
EP2651446A1 (en) 2010-12-14 2013-10-23 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
US20130331320A1 (en) 2010-12-14 2013-12-12 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
JP6058646B2 (en) 2011-06-15 2017-01-11 ノヴォ ノルディスク アー／エス Multi-substituted insulin
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP6735561B2 (en) 2012-12-03 2020-08-05 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． O-glycosylated carboxy-terminal portion (CTP) peptide-based insulin and insulin analogs
EP3004156A1 (en) 2013-06-07 2016-04-13 Novo Nordisk A/S Method for making mature insulin polypeptides
CN120060321A (en) 2014-02-28 2025-05-30 诺和诺德股份有限公司 Mating factor alpha propeptide variant
JP6983075B2 (en) 2015-06-02 2021-12-17 ノヴォ ノルディスク アー／エス Insulin with polar recombination extension
BR112018002416A2 (en) 2015-08-25 2018-09-18 Novo Nordisk As insulin derivatives and their medical uses
JP2018531899A (en) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス Novel insulin derivatives and their medical use
WO2017032795A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
AU2017269496B2 (en) * 2016-05-24 2021-03-25 Novo Nordisk A/S MIC-1 compounds and use thereof
JP2020531451A (en) 2017-08-17 2020-11-05 ノヴォ ノルディスク アー／エス New acylated insulin analogs and their use
US20210230659A1 (en) * 2018-06-18 2021-07-29 Unichem Laboratories Ltd Leader Sequence for Higher Expression of Recombinant Proteins
CN110305223B (en) * 2019-06-26 2022-05-13 重庆派金生物科技有限公司 Method for preparing target polypeptide by recombinant tandem fusion protein
FI4073097T3 (en) 2019-12-11 2024-08-13 Novo Nordisk As NEW INSULIN ANALOGUES AND THEIR METHODS OF USE
WO2023144240A1 (en) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Glucose sensitive insulin derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593518B1 (en) * 1985-05-02 1989-09-08 Transgene Sa VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
DK105489D0 (en) * 1989-03-03 1989-03-03 Novo Nordisk As POLYPEPTIDE
DK300090D0 (en) * 1990-12-19 1990-12-19 Novo Nordisk As PROCEDURE FOR PREPARING LEADER SEQUENCES
WO1992013951A1 (en) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of human serum albumin in methylotrophic yeast cells

Also Published As

Publication number Publication date
CZ363796A3 (en) 1997-05-14
IL114160A (en) 2006-12-31
FI965030L (en) 1997-02-14
CN1131312C (en) 2003-12-17
FI965030A7 (en) 1997-02-14
CA2192943A1 (en) 1995-12-28
HUT75840A (en) 1997-05-28
HU9603476D0 (en) 1997-02-28
MX9606536A (en) 1997-03-29
JPH10501695A (en) 1998-02-17
JP3730255B2 (en) 2005-12-21
FI965030A0 (en) 1996-12-16
ZA954983B (en) 1996-02-14
AU2733595A (en) 1996-01-15
BR9508053A (en) 1997-08-12
EP0765395A1 (en) 1997-04-02
SG47883A1 (en) 1998-04-17
IL114160A0 (en) 1995-10-31
PL317761A1 (en) 1997-04-28
NO965411L (en) 1997-02-14
CN1152942A (en) 1997-06-25
WO1995035384A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
NO965411D0 (en) N-terminally extended proteins expressed in yeast
DK1056883T3 (en) Yeast cell surface protein display and uses thereof
FI972030A7 (en) Purified papillomavirus proteins
DE69504085D1 (en) NAIL POLISH WITH MICROGEL PARTICLES
FI972763A7 (en) Mutant proteins
DK0821057T3 (en) baker's yeast
NO974924D0 (en) Modified polypeptides with increased immunogenicity
TR199701666A3 (en) Proteins
KR960010685A (en) Peptides and their uses
EP0804556A4 (en) PROTEIN MODIFYING ENZYME
SE9701041D0 (en) Novel proteins and their use
DE69434900D1 (en) HUMAN CHEMOKIN POLYPEPTIDE
FIU940379U0 (en) Hopsaettningsmaskin Foer in lastpalls
SE9602287D0 (en) Novel protein and methods for its use
ITCR950001V0 (en) DOUBLE MOVING FURNITURE
KR950022452U (en) Cheonggukjang Fermenter
SE9403166D0 (en) Headstones in new design
KR950022773U (en) Dead body
KR970052565U (en) Wheat Glasses
BR7400551U (en) Inverted nail
SE9600701D0 (en) The pen in place
BR7501390U (en) Constructive arrangement in cap or similar
BR9503110A (en) Improvement in buffer
FI2504U1 (en) Chair
KR970044643U (en) Defroster in flat showcase